16 March 2026: TargetMI will be presenting more of our innovation at the EIC Cardiogenomics Tech-To-Market (Leiden) event, where all seven EIC Cardiogenomics Pathfinder projects will showcase their work to potential collaborators and investors. Join us in Leiden if you are interested in forming part of the development of these exciting innovations. Limited places available.

27 Janary 2026: The TargetMI team recently hosted Prof. Gauden Galea at the University of Malta. Prof. Galea is a global health expert and public health physician, with over 25 years’ experience with the World Health Organization (WHO), including senior leadership roles in noncommunicable diseases (NCDs).

5-6 December 2025: TargetMI PI Stephanie Bezzina Wettinger and Francesca Borg-Carbott attended the European Society of Cardiology ESC Cardio Genomics conference 2025 held in Lisbon, Portugal. Several talks on approaches to gene therapy in cardiovascular disease, including siRNAs, AAV-mediated and Crispr-Cas9 approaches.

1 December 2026: Stephanie Bezzina Wettinger and Jean Paul Ebejer attended this very clear session on funding opportunities offered by Xjenza Malta for furthering innovation development.

13-14 November 2025: Stephanie Bezzina Wettinger, Principal Investigator, took the stage at MedTech World to showcase TargetMI's work and how we use our multiomic and multilayered data in our proprietary computational data analysis tool, TargetID. To learn more read the TargetMI article published on the MedTech World Website.

3 November 2025: Stephanie Bezzina Wettinger and Rosienne Farrugia from TargetMI attended the kick off meeting for the EU COST action CardioPharmaGENET. In this COST action we will review genetic effects on treatment in cardiovascular disease, raise awareness with stakeholders encouraging the clinical application of findings with sufficient evidence for action.

28 May 2025: University of Malta Research Expo 2025, University of Malta Valletta Campus, Malta. Prof. Stephanie Bezzina Wettinger gave a talk, "TargetMI: A Multi-Omics Approach for Novel Drug Targets, Biomarkers and Risk Algorithms for Myocardial Infarction." 

5 May 2025: Horizon Europe Info Days 2025 Brokerage Event on Cluster 1 Health: Stephanie Bezzina Wettinger gave a pitch on "Analysing Human Multiomic Data to Rapidly Identify Better Candidate Drug Targets." The pitch is available on YouTube at 1:36:22. 

30 January 2025: Julian's Tech Talks as part of Julian's Pathfinder Foundation: Dr. Panagiotis Alexiou lectured on "Exploring Bioinformatics: the Power of AI and Big Data in Biomedical Science."

19 December 2024: Julian's Tech Talks as part of Julian's Pathfinder Foundation: Prof. Stephanie Bezzina Wettinger lectured on "The unexpected path: From outer space to molecules, to gene, biomarker and drug discovery."

28 November 2024: Julian's Tech Talks as part of Julian's Pathfinder Foundation: Prof. Jean-Paul Ebejer lectured on "Computer-aided drug discovery."

27 September 2024, 18:00-23:00: Science in the City: "Decoding the messages of life," TargetMI and BioGeMT projects at the Triton Fountain in Valletta.

The presence of team members at Science in the City 2024 offered a unique opportunity for visitors to gain a deeper understanding of their research. Using engaging games, they explained basic concepts in the field of bioinformatics, and used machine learning to answer questions about genetics and molecular biology.

The Times of Malta featured an article about this event.

4 September 2024:  Introduction to Opportunities of European Innovation Council Programmes, Stephanie Bezzina Wettinger spoke about the EIC Pathfinder Cardiogenomics Challenge for TargetMI Project: A Multi-Omics Approach for Novel Drug Targets, Biomarkers, and Risk Algorithms for Myocardial Infarction.

1 July 2024: Stephanie Bezzina Wettinger spoke about the TargetMI and BioGeMT projects at a press conference for the launch of Xjenza Malta, the new agency replacing the Malta Council for Science and Technology (MCST). TVM News featured an article about this event.

25 May 2024: Stephanie Bezzina Wettinger presented "How genetics influences the risk of heart attacks" on behalf of the TargetMI and BioGeMT projects at Science Fest at St. Monica School Gzira.

11 May 2024: TargetMI and BioGeMT projects at KurżitàJiem 2024 at Esplora Interactive Science Centre in Malta.

12 March 2024: Stephanie Bezzina Wettinger presented on the topic, "How a 30-Year Journey in Research May Lead to Better Ways to Combat Heart Disease" at the School of Practical Philosophy in Malta.

1-20 December 2023: Internal Training for TargetMI and BioGeMT team members by BioGeMT ERA Chair, Panagiotis Alexiou.